Chapter 36 – New treatments for multiple sclerosisChapter 36 – New treatments for multiple sclerosisThis chapter presents an overview of new treatments for multiple sclerosis (MS). MS is a disease of the central nervous system (CNS) in which the demyelination and synthesis of immunoglobu...
Major EO, Yousry TA, Clifford DB (2018) Pathogenesis of progressive multifocal leukoencephalopathy and risks associ- ated with treatments for multiple sclerosis: a decade of lessons learned. Lancet Neurol 17:467-480. https://doi.org/10.1016/ S1474-4422(18)30040-1...
Multiple Sclerosis Treatments Although there is currently no cure for multiple sclerosis (MS), current treatments focus on limiting further damage, easing symptoms, and avoiding complications. If you have a type of multiple sclerosis calledrelapsing-remitting MSand your condition is acting up, your do...
Disease-modifying treatments for multiple sclerosis -- a review of approved medications. European Journal of Neurol- ogy. 2015;23:18-27. https://doi.org/10.1111/ene.12883Torkildsen, Myhr KM, Bo L, et al. (2016) Disease-modifying treatments for multiple sclerosis - a review of approved ...
Abstract Stimulated by the successful introduction of interferon-β as treatment for relapsing-remitting multiple sclerosis (MS) and based on an improved knowledge of the immunopathology of MS, a vast array of treatment options is currently under investigation for disease course modification. These are...
We summarize MRI measures currently available to assess treatment efficacy and safety in multiple sclerosis (MS) clinical trials and discuss novel metrics that could enter the clinical arena in the near future. In relapsing remitting MS, MRI measures of disease activity (new T2 and gadolinium-...
Multiple sclerosis affects 2.5 million people worldwide, including 400,000 Americans. Get in-depth multiple sclerosis information here on symptoms and treatments of MS.
Multiple sclerosis (MS) is a chronic neurological disorder, which can lead to a wide range of disabling symptoms. The condition has a significant negative impact on health-related quality of life, and the economic cost of the disease is substantial. Decision-making regarding treatments for MS, ...
Monoclonal antibodies (MAbs) may have great potential as therapies for autoimmune diseases. Their development as treatments for multiple sclerosis (MS) is promising. Partially effective immunomodulatory therapies have been helpful for many MS patients; however, for patients failing these immunomodulatory tre...
(Medical Xpress)—New treatments for multiple sclerosis (MS) using common anti-psychotic agents have been discovered by Victoria University of Wellington researchers. The study led by Dr Anne La Flamme, an associate professor in the School of Biological Sciences and head of the MS research programm...